[{SET customtitle='Zatloukal, Univ.-Prof. Dr.med.univ. Kurt (Medizin)'}]
!!!Zatloukal, Kurt 

~* 4. 3. 1959, Graz

__Univ.-Prof. Dr.med.univ. Kurt Zatloukal__


[{Image src='Zatloukal_02.jpg' caption='' width='200' class='image_left' alt='Zatloukal' height='216'}]

Professor of Pathology, Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25, A-8036 Graz; phone: +43-316-380 4404, fax: +43-316-384 329, e-mail: kurt.zatloukal@medunigraz.at

!Personal Data

	Date of Birth:	March 4th, 1959 \\
	Place of Birth:	Graz, Austria \\
	Nationality:	Austrian \\

	1977-1985: Medical School, University of Graz\\
	1985: M.D. degree (Dr.)\\
!Career History

	1985-1991: Residence for pathologist at the Institute of Pathology, University of Graz, Austria (Head: Prof. Helmut Denk), with specialization in Molecular Pathology\\
	1992:		Habilitation in Molecular Pathology\\
	1991-1993:	Postdoc at the Research Institute of Molecular Pathology (I.M.P), Vienna,Austria, in the group of Prof. Max L. Birnstiel (development of gene therapies for cancer)\\
	1997:		Professor of Pathology\\
!Career-related Activities & Memberships

	2000 – 2003:	Member of the board of the Austrian Science Fund\\
	2001 - 2009:	Member of the Bioethics Commission at the Federal Chancellery\\
	2001:		Founder of Oridis-Biomed (CEO 2001-2005)\\
	2002 - 2005:	President of the Austrian Society of Genetics and Gene Technology\\
	2002:		Corresponding member of the Austrian Academy of Sciences\\
	2002 - 2007:	Member of the OECD task force on biological resource centres\\
	2004 - 2011	Member of the Roadmap (thematic) Working Group of the European Strategy Forum on Research Infrastructure (ESFRI)\\ 
	2009:		Member of the Austrian “Arzneimittelbeirat”\\
	2009:		Santa Chiara Chair at the University of Siena\\
	2009:		Honorary Professor of the University of Dundee\\
	2010:		Director of the Christian Doppler Laboratory “ Biospecimen Research and	Biobanking Technologies”


155 publications, 14 patents\\

!Research Fields

The research work focuses on molecular pathology of metabolic liver diseases and cancer. Kurt Zatloukal coordinated the preparatory phase of a European biobanking and biomolecular research infrastructure (BBMRI) within the 7th EU framework programme. BBMRI should provide access to high quality human biological samples to enable future needs of large genetic epidemiology and sequencing studies. In this context it is crucial to establish Europe-wide harmonized processes and quality criteria that are compliant with the requirements of latest -omics technologies as well as with ethical and legal regulations. Furthermore, he leads in the FP7-funded large integrated project SPIDIA the development of new European standards and norms for tissue-based biomarkers, and leads the medical platform of the FET Flagship project IT Future of Medicine.

Kurt Zatloukal was member of the OECD task force on biological resource centres and the Roadmap Working Group of the European Strategy Forum on Research Infrastructures. Moreover, he contributed to the OECD best practice guidelines for biological resource centres, the regulations for genetic testing of the Austrian Gene Technology Law, and the opinion on Biobanks for research of the Bioethics Commission at the Austrian Federal Chancellery.

Stand: 2013